siRNA, Anti-Pabpn1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT99944WQ-LNA)

The product SIRGT99944WQ-LNA is a type of small interfering RNA (siRNA) that targets Pabpn1 gene and regulates the expression of gene. The siRNA interferes with the expression of Pabpn1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_019402.2
Alternative Names PAB2; Pabp3; mPABII
Related Diseases Oculopharyngeal Muscular Dystrophy
Purification HPLC
Target Gene
Gene ID 54196
Uniprot ID Q8CCS6
Sub Cat Target Species Modification Scale  
SIRGT26156WQ-2OMe PABPN1 Human 2ʹ-O-methyl (2'-OMe) Inquiry
SIRGT27156WQ-2F PABPN1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT28156WQ-2MOE PABPN1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT98944WQ-2MOE Pabpn1 Mouse 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT26156WQ-RB PABPN1 Human Ribo-modified Inquiry
SIRGT96944WQ-RB Pabpn1 Mouse Ribo-modified Inquiry
SIRGT27156WQ-BB PABPN1 Human Backbone-modified Inquiry
SIRGT97944WQ-BB Pabpn1 Mouse Backbone-modified Inquiry

Related Products